News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Drug updates   Suboxone SL tablets replaced by SL film in US Sublingual (SL) combination tablets containing buprenorphine and naloxone (Suboxone®; Reckitt Benckiser, Warren, NJ, USA), are being replaced by a sublingual film in the US. The […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Hot topics   EMA review of cardiovascular safety of NSAIDs The European Medicines Agency (EMA) has finalised a review of recently published information on the cardiovascular safety of non-steroidal anti-inflammatory drugs (NSAIDs). The review confirms the findings […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Latest additions   PDF version of PCF4+ now available! An e-book PDF version containing the latest content of the on-line Palliative Care Formulary as of September 2012 (designated PCF4+) is now available to purchase and download from […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Drug updates   Hydromorphone ER 32mg launched in US A once daily modified-release hydromorphone 32mg tablet (Exalgo; Mallinckrodt, Hazelwood, MO) has been added to the existing product range of 8mg, 12mg and 16mg modified-release tablets for opioid-tolerant […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Safety updates   FDA warn of skin injury with OTC rubefacients Rare cases of serious burns on the skin have been reported to the US Food and Drug Administration (FDA) where over-the-counter (OTC) topical muscle and joint […]

Read More…

SHORTCUTS

Cancer. 2012 Chemotherapy use and patient treatment preferences in advanced colorectal cancer: A prospective cohort study.   Zafar SY, Malin JL, Grambow SC, Abbott DH, Kolimaga JT, Zullig LL, Weeks JC, Ayanian JZ, Kahn KL, Ganz PA, Catalano PJ, West DW, Provenzale D; for the Cancer Care Outcomes Research & Surveillance (CanCORS) Consortium. This national […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Hot topics   Liverpool Care Pathway consensus statement Over 20 organisations have signed a consensus statement in support of the Liverpool Care Pathway for the dying patient, including professional bodies, third sector organizations, disease specific charities and […]

Read More…

SHORTCUTS

Ann Surg Oncol. 2012 Nov 10. [Epub ahead of print] Longitudinal Changes in Function, Symptom Burden, and Quality of Life in Patients with Early-Stage Lung Cancer. Koczywas M, Williams AC, Cristea M, Reckamp K, Grannis Jr FW, Tiep BL, Uman G, Ferrell B. This study evaluated the longitudinal changes (up to 1 year) in physical […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Hot topics   DH consultation: Governance arrangements for controlled drugs The Department of Health (DH) is consulting on proposed changes to the governance arrangements for controlled drugs in England and Scotland, including the role and functions of […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Drug updates   Ketamine injection supply problems Pfizer UK has confirmed that there is a supply problem with ketamine (Ketalar) 10mg/mL and 100mg/mL injection. All orders for these products are now being re-directed to a Pfizer central […]

Read More…